| Application no. and date | 20726959.8 (espacenet) (Federated) (European Patent Register), 20200515 | | Patent/reg. no. and date | DK/EP 3969117, 20260325 | | Publication date | 20220323 | | Priority no. and date | US 201962848857 P, 20190516, US 201962949599 P, 20191218 | | EP pub. no. and date |
EP 3969117 20220323 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P200573EPDK/SH/NN | | Inventor | GRANDEURY, Arnaud, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
DODD, Stephanie Kay, c/o Novartis Institutes
for Bio Medical Research, Inc.,
250 Massachusetts Avenue,
Cambridge, New Jersey 02139, US,
ROUSAKI, Evgenia, c/o Novartis Pharma AG Postfach
4002 Basel, CH,
SUFFERT, Emmanuel, c/o Novartis Pharma AG Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 401/14 (2006.01) | | Title | KRYSTALLINSKE FORMER AF N-[4-(CHLORDIFLUORMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL]-5-(1H-PYRAZOL-5-YL)PYRIDIN-3-CARBOXAMID | | Int. application no. | IB2020054628 | | Int. publication no. | WO2020230099 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
